ARDELYX, INC.
Last · —$3.19+0.07 (+2.24%)live · yahoo · 2h ago
Vol 4.05M ≈ 13.26M
MA10MA20MA50
Market cap$823.62M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal nameARDELYX, INC.
HQUnited States (US)
ListingUS ARDX
ISINUS0396971071
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2834
CurrencyUSD
Entity registrysec:0001437402
CIK0001437402
Websitewww.ardelyx.com
Employees489
AddressArdelyx, Inc. 400 5th Avenue 02451, Waltham +510 745 1700
| Revenue | $450.9M |
|---|---|
| Operating income | $-35.5M |
| Net income | $-54.3M |
| Free cash flow | $-38.7M |
| Operating margin | -7.9% |
| Net margin | -12.0% |
| Return on equity | -36.5% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-02-19
From latest 10-K · 2026-02-19
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -15.1%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -10.4%
- Cash Runway Low — Cash runway ~1.6 years
- Accumulated Deficit High — Accumulated deficit / equity 567%
Upcoming earnings
THU.29OCT
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.02
Est. revenue
129.0M
Earnings transcripts
Documents
FormReporting forFiledFlags
Showing 5 of 141 filings